Viridian Therapeutics, Inc.\DE

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Viridian Therapeutics, Inc.\DE
CIK #0001590750
EDGAR Form CIK 2011 - 2025
10-K [0001590750]
10-Q [0001590750]
3 [0001590750]
4 [0001590750]
5 [0001590750]
8-K [0001590750]
D [0001590750]
SC 13D [0001590750]
SC 13G [0001590750]
Form 13D/13G Filer Form 13D/13G Subject Filed
Kynam Capital Management LP Viridian Therapeutics Inc de [2025-05-15]
Commodore Capital LP Viridian Therapeutics Inc de [2025-04-11]
Perceptive Advisors LLC Viridian Therapeutics Inc de [2024-01-29]
State Street Corp Viridian Therapeutics Inc de [2024-01-24]
FMR LLC Viridian Therapeutics Inc de [2024-01-10]
Venrock Opportunities Fund LP Viridian Therapeutics Inc de [2023-12-08]
Paradigm Biocapital Advisors LP Viridian Therapeutics Inc de [2023-05-11]
Vanguard Group Inc Viridian Therapeutics Inc de [2023-02-09]
BlackRock Inc Viridian Therapeutics Inc de [2023-02-03]
Millennium Management LLC Viridian Therapeutics Inc de [2022-05-31]
Commodore Capital LP Viridian Therapeutics Inc de [2022-05-19]
Paradigm Biocapital Advisors LP Viridian Therapeutics Inc de [2022-02-14]
Avidity Partners Management LP Viridian Therapeutics Inc de [2021-10-28]
Venrock Healthcare Capital Partners III LP Viridian Therapeutics Inc de [2021-10-14]
Vivo Opportunity LLC Viridian Therapeutics Inc de [2021-09-30]
Deep Track Capital LP Viridian Therapeutics Inc de [2021-09-24]
TCG Crossover Management LLC Viridian Therapeutics Inc de [2021-09-10]
Frazier Life Sciences Public Fund LP Viridian Therapeutics Inc de [2021-08-26]
D E Shaw & Co LP Viridian Therapeutics Inc de [2021-05-10]
Wellington Management Group LLP Viridian Therapeutics Inc de [2021-03-10]
Hawkes Bay Master Investors Cayman LP Viridian Therapeutics Inc de [2021-02-19]
Cormorant Asset Management LP Viridian Therapeutics Inc de [2021-01-19]
Citadel Advisors LLC Miragen Therapeutics Inc [2021-01-11]
Xencor Inc Miragen Therapeutics Inc [2021-01-11]
Ally Bridge Medalpha Master Fund LP Miragen Therapeutics Inc [2021-01-07]
Fairmount Funds Management LLC Miragen Therapeutics Inc [2021-01-05]
RA Capital Management LP Miragen Therapeutics Inc [2020-12-17]
Biotechnology Value Fund L P Miragen Therapeutics Inc [2020-11-09]
Logos Global Management LP Miragen Therapeutics Inc [2020-11-09]
Point72 Asset Management LP Miragen Therapeutics Inc [2020-10-29]
683 Capital Partners LP Miragen Therapeutics Inc [2019-01-03]
JAFCO SV4 Investment Limited Partnership Miragen Therapeutics Inc [2017-04-03]
FMR LLC Miragen Therapeutics Inc [2017-03-10]
Boulder Ventures V LP Miragen Therapeutics Inc [2017-02-24]
Atlas Venture Fund VII L P Miragen Therapeutics Inc [2017-02-23]
Remeditex Ventures LLC Miragen Therapeutics Inc [2017-02-17]
Peierls E Jeffrey Signal Genetics Inc [2015-03-20]
Empery Asset Management LP Signal Genetics Inc [2015-02-20]
Heartland Advisors Inc Signal Genetics Inc [2015-02-13]
Lebow 2012 Nevada Trust Signal Genetics Inc [2015-02-11]
LFIT-A Trust Signal Genetics Inc [2015-02-11]
Lebow Alpha LLLP Signal Genetics Inc [2015-02-11]
Form 3/4/5 Subject 2011 - 2025
Viridian Therapeutics, Inc.\DE
Moses Jennifer K.
Morris Arlene
Ajer Jeffrey Robert
Gheuens Sarah
Cain Christopher W
Kiselak Tomas
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund II L.P.
Fairmount Funds Management LLC
View All
Terms | Privacy | Guide
tony@aum13f.com